Literature DB >> 7042538

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.

F K Jansen, H E Blythman, D Carrière, P Casellas, O Gros, P Gros, J C Laurent, F Paolucci, B Pau, P Poncelet, G Richer, H Vidal, G A Voisin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7042538     DOI： 10.1111/j.1600-065x.1982.tb00394.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  23 in total

1.  Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.

Authors:  R P Moseley; J C Benjamin; R D Ashpole; N M Sullivan; J A Bullimore; H B Coakham; J T Kemshead
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain.

Authors:  O Rostaing-Capaillon; P Casellas
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.

Authors:  M Colombatti; C Bron
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

4.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 5.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

Review 6.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.

Authors:  K S Webb; S N Liberman; J L Ware; P J Walther
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.

Authors:  C K Tebbi; D Chervinsky; B K Seon
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; Y Ono; Y Koide; N Ishida; K Yoshinaga
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.

Authors:  C F Scott; V S Goldmacher; J M Lambert; R V Chari; S Bolender; M N Gauthier; W A Blättler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.